撒哈拉以南非洲淋病奈瑟菌与生殖支原体抗菌药物耐药性的系统综述
该系统综述检索三个电子数据库2000年1月1日至2020年5月26日发表的研究,纳入40项研究,汇总撒哈拉以南非洲15个国家7961株淋病奈瑟菌分离株和南非350份生殖支原体标本的耐药数据。所有四个撒哈拉以南非洲地区均报告淋病奈瑟菌对环丙沙星、四环素和青霉素的耐药率很高,除西非外所有地区均观察到对头孢克肟或头孢曲松的耐药,所有地区均报告阿奇霉素耐药。作者结论认为需要加强撒哈拉以南非洲的抗菌药物耐药监测。
要点
- 撒哈拉以南非洲四个地区淋病奈瑟菌对环丙沙星、四环素和青霉素耐药率均很高。
- 除西非外所有地区观察到淋病奈瑟菌对头孢克肟或头孢曲松耐药,所有地区报告阿奇霉素耐药。
- 南非生殖支原体报告大环内酯类和氟喹诺酮类相关耐药。
核心结论
- 需要加强撒哈拉以南非洲的抗菌药物耐药监测,以便及时发现和通报性传播感染的耐药。
研究设计与样本
- 系统综述,检索三个电子数据库2000年1月1日至2020年5月26日发表的研究。
- 纳入40项研究,报告撒哈拉以南非洲15个国家7961株淋病奈瑟菌分离株和南非350份生殖支原体标本的耐药数据。
- 采用叙述性综合汇总数据。
主要发现
- 所有四个撒哈拉以南非洲地区均报告淋病奈瑟菌对环丙沙星、四环素和青霉素的耐药率很高。
- 除西非外所有地区均观察到淋病奈瑟菌对头孢克肟或头孢曲松的耐药。
- 所有地区均报告淋病奈瑟菌阿奇霉素耐药,阿奇霉素被推荐作为与广谱头孢菌素联合治疗淋病的一部分。
- 南非报告生殖支原体大环内酯类和氟喹诺酮类相关耐药。
- 未检索到关于沙眼衣原体和阴道毛滴虫抗菌药物耐药的研究。
局限性
- 未检索到关于沙眼衣原体和阴道毛滴虫抗菌药物耐药的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Limited antimicrobial resistance (AMR) surveillance coupled with syndromic management of sexually transmitted infections (STIs) in sub-Saharan Africa (SSA) could be contributing to an increase in AMR in the region. This systematic review aimed to synthesize data on the prevalence of AMR in common STIs in SSA and identify some research gaps that exist. METHODS: We searched three electronic databases for studies published between 1 January 2000 and 26 May 2020. We screened the titles and abstracts for studies that potentially contained data on AMR in SSA. Then we reviewed the full text of these studies to identify articles that reported data on the prevalence of AMR in Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma genitalium in SSA. We summarized the data using a narrative synthesis. RESULTS: The 40 included studies reported on AMR data from 7961 N. gonorrhoeae isolates from 15 countries in SSA and 350 M. genitalium specimens from South Africa. All four SSA regions reported very high rates of ciprofloxacin, tetracycline and penicillin resistance in N. gonorrhoeae. Resistance to cefixime or ceftriaxone was observed in all regions except West Africa. Azithromycin resistance, recommended as part of dual therapy with an extended-spectrum cephalosporin for gonorrhoea, was reported in all the regions. Both macrolide and fluoroquinolone-associated resistance were reported in M. genitalium in South Africa. Studies investigating AMR in C. trachomatis and T. vaginalis were not identified. CONCLUSIONS: There is a need to strengthen AMR surveillance in SSA for prompt investigation and notification of drug resistance in STIs.
引用
- Iwuji C, Pillay D, Shamu P, et al. A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa. J Antimicrob Chemother. 2022. PMID: 35578892. doi:10.1093/jac/dkac159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。